Media centre

Press releases

26/11/2007

Antisoma to present at Piper Jaffray and Lazard Capital Markets conferences

26 November 2007, London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive, Glyn Edwards, will be presenting at the Piper Jaffray and Lazard Capital Markets healthcare conferences in New York.

The presentation at Piper Jaffray is scheduled for 13:00 EST (18:00 GMT) on Tuesday, November 27th.

The presentation at Lazard Capital Markets is scheduled for 11:00 EST (16:00 GMT) on Wednesday, November 28th.

Webcasts of the presentations will be available to all on Antisoma's website at www.antisoma.com.

For live viewing of the webcasts, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Background on Antisoma
Headquartered in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information.